History of negative colorectal endoscopy and risk of rectosigmoid neoplasms at screening flexible sigmoidoscopy

Luigina Bonelli, Stefania Sciallero, Carlo Senore, Marco Zappa, Hugo Aste, Bruno Andreoni, Donato Angioli, Roberto Ferraris, Stefano Gasperoni, Giuseppe Malfitana, Marco Pennazio, Wendy Atkin, Nereo Segnan

Research output: Contribution to journalArticle

Abstract

Background and aims: Screening sigmoidoscopy can reduce incidence of colorectal cancer and mortality. The optimal re-screening interval has not yet been defined. This study is aimed at estimating the risk of distal advanced adenomas (diameter ≥10 mm, villous component >20%, high-grade dysplasia) and cancer at screening flexible sigmoidoscopy in subjects aged 55-64 years who reported pre-screening negative colorectal endoscopy. Patients: Eight thousands two hundred two subjects aged 55-6 4 years who underwent screening flexible sigmoidoscopy within the SCORE trial in Italy and who were able to report their previous history of colorectal endoscopy. Results: Eight hundred eighty three of 8,202 subjects (10.8%) reported at least one prescreening negative endoscopy: among them, after 3-5 years, 6-10 years and >10 years intervals between last reported examination and screening endoscopy, the Absolute Risk of advanced adenomas was 1.5%, 0.9% and 0.9%; one cancer was detected (0.1%). Among the 7,319 subjects who did not report prescreening endoscopy the risks of advanced adenoma and cancer were 3.2% and 0.4%, respectively. Subjects with a previous colorectal examination had a 65% decreased risk of advanced adenomas (OR=0.35, 95%CI 0.18-0.66) and a 71% decreased risk of cancer (OR=0.29, 95%CI 0.04-1.12) as compared to those who did not. For subjects without family history of colorectal cancer the statistically significant decrease of the risk persisted up to ten years. The observed benefit seems not to apply to subjects with family history of colorectal cancer. Conclusions: Our results are consistent with the hypothesis that the interval between screening sigmoidoscopies could be safely expanded beyond 5 years for subjects without specific risk factors for colorectal cancer.

Original languageEnglish
Pages (from-to)105-113
Number of pages9
JournalInternational Journal of Colorectal Disease
Volume21
Issue number2
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Sigmoidoscopy
Endoscopy
Adenoma
Colorectal Neoplasms
Neoplasms
Early Detection of Cancer
Italy
Mortality
Incidence

ASJC Scopus subject areas

  • Gastroenterology

Cite this

History of negative colorectal endoscopy and risk of rectosigmoid neoplasms at screening flexible sigmoidoscopy. / Bonelli, Luigina; Sciallero, Stefania; Senore, Carlo; Zappa, Marco; Aste, Hugo; Andreoni, Bruno; Angioli, Donato; Ferraris, Roberto; Gasperoni, Stefano; Malfitana, Giuseppe; Pennazio, Marco; Atkin, Wendy; Segnan, Nereo.

In: International Journal of Colorectal Disease, Vol. 21, No. 2, 03.2006, p. 105-113.

Research output: Contribution to journalArticle

Bonelli, L, Sciallero, S, Senore, C, Zappa, M, Aste, H, Andreoni, B, Angioli, D, Ferraris, R, Gasperoni, S, Malfitana, G, Pennazio, M, Atkin, W & Segnan, N 2006, 'History of negative colorectal endoscopy and risk of rectosigmoid neoplasms at screening flexible sigmoidoscopy', International Journal of Colorectal Disease, vol. 21, no. 2, pp. 105-113. https://doi.org/10.1007/s00384-005-0775-9
Bonelli, Luigina ; Sciallero, Stefania ; Senore, Carlo ; Zappa, Marco ; Aste, Hugo ; Andreoni, Bruno ; Angioli, Donato ; Ferraris, Roberto ; Gasperoni, Stefano ; Malfitana, Giuseppe ; Pennazio, Marco ; Atkin, Wendy ; Segnan, Nereo. / History of negative colorectal endoscopy and risk of rectosigmoid neoplasms at screening flexible sigmoidoscopy. In: International Journal of Colorectal Disease. 2006 ; Vol. 21, No. 2. pp. 105-113.
@article{d6e1799a3d25435a82c708de2dee0088,
title = "History of negative colorectal endoscopy and risk of rectosigmoid neoplasms at screening flexible sigmoidoscopy",
abstract = "Background and aims: Screening sigmoidoscopy can reduce incidence of colorectal cancer and mortality. The optimal re-screening interval has not yet been defined. This study is aimed at estimating the risk of distal advanced adenomas (diameter ≥10 mm, villous component >20{\%}, high-grade dysplasia) and cancer at screening flexible sigmoidoscopy in subjects aged 55-64 years who reported pre-screening negative colorectal endoscopy. Patients: Eight thousands two hundred two subjects aged 55-6 4 years who underwent screening flexible sigmoidoscopy within the SCORE trial in Italy and who were able to report their previous history of colorectal endoscopy. Results: Eight hundred eighty three of 8,202 subjects (10.8{\%}) reported at least one prescreening negative endoscopy: among them, after 3-5 years, 6-10 years and >10 years intervals between last reported examination and screening endoscopy, the Absolute Risk of advanced adenomas was 1.5{\%}, 0.9{\%} and 0.9{\%}; one cancer was detected (0.1{\%}). Among the 7,319 subjects who did not report prescreening endoscopy the risks of advanced adenoma and cancer were 3.2{\%} and 0.4{\%}, respectively. Subjects with a previous colorectal examination had a 65{\%} decreased risk of advanced adenomas (OR=0.35, 95{\%}CI 0.18-0.66) and a 71{\%} decreased risk of cancer (OR=0.29, 95{\%}CI 0.04-1.12) as compared to those who did not. For subjects without family history of colorectal cancer the statistically significant decrease of the risk persisted up to ten years. The observed benefit seems not to apply to subjects with family history of colorectal cancer. Conclusions: Our results are consistent with the hypothesis that the interval between screening sigmoidoscopies could be safely expanded beyond 5 years for subjects without specific risk factors for colorectal cancer.",
author = "Luigina Bonelli and Stefania Sciallero and Carlo Senore and Marco Zappa and Hugo Aste and Bruno Andreoni and Donato Angioli and Roberto Ferraris and Stefano Gasperoni and Giuseppe Malfitana and Marco Pennazio and Wendy Atkin and Nereo Segnan",
year = "2006",
month = "3",
doi = "10.1007/s00384-005-0775-9",
language = "English",
volume = "21",
pages = "105--113",
journal = "International Journal of Colorectal Disease",
issn = "0179-1958",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - History of negative colorectal endoscopy and risk of rectosigmoid neoplasms at screening flexible sigmoidoscopy

AU - Bonelli, Luigina

AU - Sciallero, Stefania

AU - Senore, Carlo

AU - Zappa, Marco

AU - Aste, Hugo

AU - Andreoni, Bruno

AU - Angioli, Donato

AU - Ferraris, Roberto

AU - Gasperoni, Stefano

AU - Malfitana, Giuseppe

AU - Pennazio, Marco

AU - Atkin, Wendy

AU - Segnan, Nereo

PY - 2006/3

Y1 - 2006/3

N2 - Background and aims: Screening sigmoidoscopy can reduce incidence of colorectal cancer and mortality. The optimal re-screening interval has not yet been defined. This study is aimed at estimating the risk of distal advanced adenomas (diameter ≥10 mm, villous component >20%, high-grade dysplasia) and cancer at screening flexible sigmoidoscopy in subjects aged 55-64 years who reported pre-screening negative colorectal endoscopy. Patients: Eight thousands two hundred two subjects aged 55-6 4 years who underwent screening flexible sigmoidoscopy within the SCORE trial in Italy and who were able to report their previous history of colorectal endoscopy. Results: Eight hundred eighty three of 8,202 subjects (10.8%) reported at least one prescreening negative endoscopy: among them, after 3-5 years, 6-10 years and >10 years intervals between last reported examination and screening endoscopy, the Absolute Risk of advanced adenomas was 1.5%, 0.9% and 0.9%; one cancer was detected (0.1%). Among the 7,319 subjects who did not report prescreening endoscopy the risks of advanced adenoma and cancer were 3.2% and 0.4%, respectively. Subjects with a previous colorectal examination had a 65% decreased risk of advanced adenomas (OR=0.35, 95%CI 0.18-0.66) and a 71% decreased risk of cancer (OR=0.29, 95%CI 0.04-1.12) as compared to those who did not. For subjects without family history of colorectal cancer the statistically significant decrease of the risk persisted up to ten years. The observed benefit seems not to apply to subjects with family history of colorectal cancer. Conclusions: Our results are consistent with the hypothesis that the interval between screening sigmoidoscopies could be safely expanded beyond 5 years for subjects without specific risk factors for colorectal cancer.

AB - Background and aims: Screening sigmoidoscopy can reduce incidence of colorectal cancer and mortality. The optimal re-screening interval has not yet been defined. This study is aimed at estimating the risk of distal advanced adenomas (diameter ≥10 mm, villous component >20%, high-grade dysplasia) and cancer at screening flexible sigmoidoscopy in subjects aged 55-64 years who reported pre-screening negative colorectal endoscopy. Patients: Eight thousands two hundred two subjects aged 55-6 4 years who underwent screening flexible sigmoidoscopy within the SCORE trial in Italy and who were able to report their previous history of colorectal endoscopy. Results: Eight hundred eighty three of 8,202 subjects (10.8%) reported at least one prescreening negative endoscopy: among them, after 3-5 years, 6-10 years and >10 years intervals between last reported examination and screening endoscopy, the Absolute Risk of advanced adenomas was 1.5%, 0.9% and 0.9%; one cancer was detected (0.1%). Among the 7,319 subjects who did not report prescreening endoscopy the risks of advanced adenoma and cancer were 3.2% and 0.4%, respectively. Subjects with a previous colorectal examination had a 65% decreased risk of advanced adenomas (OR=0.35, 95%CI 0.18-0.66) and a 71% decreased risk of cancer (OR=0.29, 95%CI 0.04-1.12) as compared to those who did not. For subjects without family history of colorectal cancer the statistically significant decrease of the risk persisted up to ten years. The observed benefit seems not to apply to subjects with family history of colorectal cancer. Conclusions: Our results are consistent with the hypothesis that the interval between screening sigmoidoscopies could be safely expanded beyond 5 years for subjects without specific risk factors for colorectal cancer.

UR - http://www.scopus.com/inward/record.url?scp=31544482728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31544482728&partnerID=8YFLogxK

U2 - 10.1007/s00384-005-0775-9

DO - 10.1007/s00384-005-0775-9

M3 - Article

C2 - 15864604

AN - SCOPUS:31544482728

VL - 21

SP - 105

EP - 113

JO - International Journal of Colorectal Disease

JF - International Journal of Colorectal Disease

SN - 0179-1958

IS - 2

ER -